# Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine

> **NCT00717834** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 400 (estimated)

## Conditions studied

- Ross River Virus Disease (RRVD)

## Interventions

- **BIOLOGICAL:** Formalin-treated, UV-inactivated, whole-virion, Vero cell-derived, preservative free Ross River Virus (RRV) vaccine with or without an Al(OH)3 adjuvant

## Key facts

- **NCT ID:** NCT00717834
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-10
- **Final completion:** 2009-10
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717834, "Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00717834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*